QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data New software advances precision medicine by enabling smaller and decentralized labs to adopt NGS testing with efficiency, consistency and confidence Combination of QCI Secondary Analysis and QCI Interpret provide a secure and compliant environment for […]

Mark Stevenson, with more than 30 years of experience in the life sciences sector, formerly Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific joins Ultima Genomics’ Board of Directors FREMONT, Calif. —  Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that Mark Stevenson will join its […]

ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology ELITech offers the proprietary, fully automated sample-to-answer (S2A) systems InGenius® and BeGenius® for molecular testing in mid-sized hospitals Diversified ELITech MDx assay portfolio focused on esoteric infectious disease testing ELITech has its R&D, […]

With researchers, The Hon. David Harris MP, NSW Minister for Medical Research, and Madeleine Jandura who was diagnosed with ulcerative colitis at age 11. Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, […]

SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. […]

Oxford, UK – OGT, a leading global provider of genomic research and diagnostic solutions, announces the launch of the RNA-based SureSeq™ Myeloid Fusion Panel, a new next-generation sequencing (NGS) tool for identifying key fusion genes implicated in acute myeloid leukaemia (AML). Intelligently designed in collaboration with leading myeloid cancer experts, the SureSeq Myeloid Fusion Panel […]

Collaboration Helps Simplify Lab Operations and Improve Data Quality for Users INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an expert in genomics tools development for high-stringency clinical and translational applications. The partnership harnesses the value of each organization to deliver […]

Lonza customers can now access TriLink’s CleanCap® mRNA capping technology for non-commercial use, enabling further development of critical mRNA therapeutics SAN DIEGO — TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company’s Board of Directors, April 24, 2024. Dr. Klimovsky will serve as a member of the Science and Technology Committee. Following the appointment, the board of Bio-Techne will be temporarily comprised of eleven directors, ten […]